Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

Author(s):
Lindner, L.H.; Litiere, S.; Sleijfer, S.; Benson, C.; Italiano, A.; Kasper, B.; Messiou, C.; Gelderblom, H.; Wardelmann, E.; Cesne, A. le; Blay, J.Y.; Marreaud, S.; Hindi, N.; Desar, I.M.E.; Gronchi, A.; Graaf, W.T.A. van der
Published
2018
Publication type
Article / Letter to editor
soft tissue sarcomaprognostic factorslung metastasesEORTC
Date issued
2018-06-15
Language
English
Is part of
International Journal of Cancer (2018), Vol. 142, no. 12, p. 2610-2620
hdl
1887/96269
doi
10.1002/ijc.31286